160308-35-0

Upstream product

• 1053697-06-5 1-{(2R,3R,4R,4aR,10aR)-4-Hydroxy-6,6,8,8-tetraisopropyl-3-[(4-methoxy-phenyl)-diphenyl-methoxy]-hexahydro-1,5,7,9-tetraoxa-6,8-disila-benzocycloocten-2-yl}-5-methyl-1H-pyrimidine-2,4-dione 
• 20197-20-0 1-(2′,3′,4′,6′-tetra-O-acetyl-β-D-galactopyranosyl)-thymine 
• 65-71-4 thymin 
• 160308-29-2 1-<4,6-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-galactopyranosyl>thymine 
• 4163-60-4 β-D-galactose peracetate 
• 20183-21-5 1-(β-D-galactopyranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione 

Relevant academic research and scientific papers

New Acyclic Nucleoside Analogues. Stereospecific Synthesis of Purines and Pyrimidines Substituted with Chiral Chains by Sugar-ring Opening of &β-D-Galactopyranosyl Nucleosides

2',3'- and 3',4'-Seco-nucleosides, retaining the carbon framework of β-D-ribofuranosyl nucleosides but having a hydroxymethyl substituent on the 4' or 5' position, have been synthesized and their antiviral properties examined.These hitherto unknown chiral acyclic nucleosides were stereospecifically prepared by ring opening of β-D-galactopyranosyl nucleosides by means of periodate oxidation followed by borohydride reduction.None of the prepared compounds showed marked antiviral effect against a variety of DNA and RNA viruses.